Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer.

Li H, Ma F, Wang H, Lin C, Fan Y, Zhang X, Qian H, Xu B.

Int J Biol Markers. 2013 Dec 17;28(4):e357-64. doi: 10.5301/jbm.5000048.

PMID:
24338721
2.

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).

Ma F, Li H, Li Y, Ding X, Wang H, Fan Y, Lin C, Qian H, Xu B.

Medicine (Baltimore). 2017 Apr;96(14):e6561. doi: 10.1097/MD.0000000000006561.

3.

Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women.

Proctor E, Kidwell KM, Jiagge E, Bensenhaver J, Awuah B, Gyan K, Toy K, Oppong JK, Kyei I, Aitpillah F, Osei-Bonsu E, Adjei E, Ohene-Yeboah M, Brewer RN, Fondjo LA, Owusu-Afriyie O, Wicha M, Merajver S, Kleer C, Newman L.

Ann Surg Oncol. 2015 Nov;22(12):3831-5. doi: 10.1245/s10434-015-4455-x. Epub 2015 Mar 6.

4.

Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.

Tsukabe M, Shimazu K, Morimoto K, Naoi Y, Kagara N, Shimoda M, Shimomura A, Maruyama N, Kim SJ, Noguchi S.

Oncology. 2013;85(4):248-56. doi: 10.1159/000355476. Epub 2013 Oct 29.

PMID:
24192633
5.

Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.

Kida K, Ishikawa T, Yamada A, Shimada K, Narui K, Sugae S, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y, Endo I.

Breast Cancer Res Treat. 2016 Apr;156(2):261-9. doi: 10.1007/s10549-016-3738-7. Epub 2016 Mar 14.

PMID:
26975188
6.

Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.

Schwartz T, Stark A, Pang J, Awuah B, Kleer CG, Quayson S, Kingman S, Aitpillah F, Abantanga F, Jiagge E, Oppong JK, Osei-Bonsu E, Martin I, Yan X, Toy K, Adjei E, Wicha M, Newman LA.

Cancer. 2013 Feb 1;119(3):488-94. doi: 10.1002/cncr.27737. Epub 2012 Aug 28.

7.

Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.

Liebscher CA, Prinzler J, Sinn BV, Budczies J, Denkert C, Noske A, Sehouli J, Braicu EI, Dietel M, Darb-Esfahani S.

Hum Pathol. 2013 Aug;44(8):1465-71. doi: 10.1016/j.humpath.2012.12.016. Epub 2013 Mar 1.

PMID:
23465277
8.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555. Epub 2012 May 16.

PMID:
22608744
9.

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.

J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456. Epub 2011 Jun 16.

PMID:
21680574
10.

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N, Noguchi S.

Cancer Sci. 2009 Jun;100(6):1062-8. doi: 10.1111/j.1349-7006.2009.01151.x. Epub 2009 Mar 9.

11.

Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.

Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.

Mod Pathol. 2012 Feb;25(2):185-96. doi: 10.1038/modpathol.2011.160. Epub 2011 Oct 28.

12.

Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.

Ohi Y, Umekita Y, Yoshioka T, Souda M, Rai Y, Sagara Y, Sagara Y, Sagara Y, Tanimoto A.

Histopathology. 2011 Oct;59(4):776-80. doi: 10.1111/j.1365-2559.2011.03884.x.

PMID:
22014057
13.

Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.

Gong Y, Wang J, Huo L, Wei W, Ueno NT, Woodward WA.

Clin Breast Cancer. 2014 Jun;14(3):e81-8. doi: 10.1016/j.clbc.2013.12.006. Epub 2013 Dec 27.

PMID:
24461456
14.

The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.

Dong Y, Bi LR, Xu N, Yang HM, Zhang HT, Ding Y, Shi AP, Fan ZM.

Pathol Res Pract. 2013 Sep;209(9):555-61. doi: 10.1016/j.prp.2013.05.007. Epub 2013 Jun 14.

PMID:
23916993
15.

Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.

DA Cruz Paula A, Marques O, Rosa AM, DE Fátima Faria M, Rêma A, Lopes C.

Anticancer Res. 2014 Mar;34(3):1427-34.

PMID:
24596390
16.

Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.

Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S.

Breast Cancer Res Treat. 2010 Aug;123(1):97-108. doi: 10.1007/s10549-009-0619-3. Epub 2009 Nov 13.

PMID:
19911270
17.

Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.

Wu A, Luo W, Zhang Q, Yang Z, Zhang G, Li S, Yao K.

Cancer Lett. 2013 Apr 28;330(2):181-9. doi: 10.1016/j.canlet.2012.11.046. Epub 2012 Dec 5.

PMID:
23220285
18.

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.

Clin Cancer Res. 2009 Jun 15;15(12):4234-41. doi: 10.1158/1078-0432.CCR-08-1479. Epub 2009 Jun 9.

19.

Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.

Xu N, Shao MM, Zhang HT, Jin MS, Dong Y, Ou RJ, Wang HM, Shi AP.

Cancer Epidemiol. 2015 Jun;39(3):375-81. doi: 10.1016/j.canep.2015.03.003. Epub 2015 Apr 3.

PMID:
25843691
20.

Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.

Yoshioka T, Umekita Y, Ohi Y, Souda M, Sagara Y, Sagara Y, Sagara Y, Rai Y, Tanimoto A.

Histopathology. 2011 Mar;58(4):608-16. doi: 10.1111/j.1365-2559.2011.03781.x. Epub 2011 Mar 3.

PMID:
21371077

Supplemental Content

Support Center